Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)

NCT00543543 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

14840

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Cancer
Vulvar Cancer
Vaginal Cancer
Genital Warts
Human Papillomavirus Infection

Interventions

BIOLOGICAL: Comparator: GARDASIL
BIOLOGICAL: Experimental: V503

Sponsor

Merck Sharp & Dohme LLC